EGCG (epigallocatechin gallate) composition with anti-oxidation, whitening and anti-aging effects, cosmetic and preparation method of EGCG composition
Through the combination of EGCG, pineapple mushroom extract and yeast fermentation product filtrate, the problem of poor whitening and anti-wrinkle effects in cosmetics is solved, the stability and gentleness of EGCG are achieved, and the anti-oxidation and anti-wrinkle effects are significantly improved. It is suitable for many types of people. Type of cosmetics.
Patent Information
- Application Number
- CN202411147441.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-21
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-08-21
AI Technical Summary
Existing whitening and anti-wrinkle cosmetics have poor effects and high costs. The application of EGCG in cosmetics is limited by its extremely strong antioxidant and instability. The filtrate of pineapple extract and yeast fermentation product is difficult to apply on a large scale due to acidity and irritation.
EGCG, pineapple mushroom extract and yeast fermentation product filtrate are combined in a specific proportion to form an EGCG composition, which improves stability and gentleness through synergistic effects and is used as antioxidant, whitening and anti-wrinkle active components in cosmetics.
It achieves the stability, gentleness and non-irritation of EGCG composition, significantly improves the antioxidant, whitening and anti-wrinkle effects, and is suitable for facial cleansing, water, creams and other cosmetics to maintain healthy skin.
Smart Images

Figure CN119074600A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of cosmetics, and specifically relates to an EGCG composition with anti-oxidation, whitening and anti-aging effects, cosmetics and a preparation method thereof. Background Art
[0002] Due to factors such as ultraviolet rays, environmental pollution, dietary intake, and aging, human skin will experience pigmentation, skin sagging, aging, and wrinkles. In order to improve the problems of dull skin and wrinkles, seeking cosmetics that can keep the skin white, firm, and wrinkle-free is one of the main ways. However, current cosmetics with whitening and anti-wrinkle effects still have defects such as poor whitening and anti-wrinkle effects and high overall product costs.
[0003] EGCG, epigallocatechin gallate, has a molecular formula of C 22 H 18 O 11 , which is the main component of tea polyphenols, is a water-soluble component and a catechin monomer that can be separated from tea leaves. Because of its special stereochemical structure, it has very strong antioxidant activity, which is at least 100 times that of vitamin C or 25 times that of vitamin E. At present, EGCG is used in the medical field as an active ingredient with antibacterial, antiviral, antioxidant, anti-atherosclerotic, anti-thrombotic, anti-angiogenic, anti-inflammatory and anti-tumor effects. However, when it is added to conventional cosmetics, it is unstable due to its extremely strong antioxidant effect, which limits its application in the cosmetics field.
[0004] Tricholoma matsutake, also known as pine mushroom, pine mushroom, and matsutake, belongs to the basidiomycete, Tricholoma genus, and is a national second-level protected plant. It is widely distributed in Northeast and Southwest my country, especially in Yunnan. The composition of Tricholoma matsutake is relatively rich and diverse, mainly including polysaccharides, steroids, saponins, oils, triterpenes and other active ingredients, and also contains a variety of mineral elements, vitamins, and amino acids. Its extract is applied to cosmetics, which has whitening, anti-oxidation, anti-aging and other effects. Because of its strong antioxidant effect, it can also lighten skin spots, increase skin elasticity and resistance. Although Tricholoma matsutake extract has a variety of skin care effects, its cost is relatively high and it has not been widely used in cosmetics.
[0005] Many harmful bacteria on the skin can survive more easily in an alkaline environment. Maintaining an acidic environment can resist infection, give full play to the barrier function of the skin's stratum corneum, and maintain a healthy skin microecology. The yeast fermentation product filtrate is rich in natural active ingredients such as small molecule amino acids, peptides, nucleotides, vitamins, etc. It is weakly acidic, can inhibit harmful bacteria on the skin, balance oil, whiten and lighten spots, resist oxidation, and repair the skin; and its rich natural moisturizing factor (NMF) can promote the stratum corneum to be filled with moisture, which is beneficial to the absorption and conversion of nutrients. It is a very good comprehensive skin conditioner. Although the yeast fermentation product filtrate contains many nutrients, it is weakly acidic, and it is easy to irritate the skin when added to cosmetics, which limits its application in cosmetics. Summary of the invention
[0006] In view of the problems of poor whitening and anti-wrinkle effects of cosmetics in the above-mentioned prior art, the present invention provides an EGCG composition, cosmetics and a preparation method thereof.
[0007] To achieve the above purpose, the following technical solutions are specifically included:
[0008] An EGCG composition comprises the following components in parts by weight: 0.001-0.21 parts of EGCG, 0.4-4.1 parts of Tricholoma matsutake extract, and 1-10 parts of yeast fermentation product filtrate.
[0009] In the EGCG composition of the present invention, EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate have obvious synergistic effects. The combination of the three can improve the two major problems of EGCG instability and yeast fermentation product filtrate irritation, so that the EGCG composition has the characteristics of stability, mildness and non-irritation, and also has significant antioxidant, whitening and anti-aging repair effects.
[0010] Preferably, the EGCG composition comprises the following components in parts by weight: 0.02-0.2 parts of EGCG, 0.5-4 parts of Tricholoma matsutake extract, and 1-8 parts of yeast fermentation product filtrate.
[0011] Under the above weight proportions, the EGCG composition has better antioxidant, whitening and anti-wrinkle effects.
[0012] Preferably, the mass ratio of EGCG, Tricholoma matsutake extract, and yeast fermentation product filtrate is (0.05-0.2): (0.5-4) (3-6.5).
[0013] Under the above-mentioned mass ratio of EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate, the effect of the cooperation between EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate is optimal, and the antioxidant, whitening and anti-wrinkle effects of the EGCG composition are better.
[0014] A cosmetic contains the EGCG composition. The EGCG composition of the invention is used as an active component for anti-oxidation, whitening and anti-wrinkle in cosmetics.
[0015] Preferably, in the cosmetic, the mass percentage of the EGCG composition is 1-15%.
[0016] Preferably, the types of cosmetics include cleansing products, lotions, creams, and facial masks.
[0017] Preferably, the cosmetic further comprises at least one of an emollient, a dispersant, a humectant, a preservative, an emulsion stabilizer, a thickener, and a pH adjuster.
[0018] Preferably, the cosmetic comprises the following components in percentage by weight: 1-15% of the EGCG composition, 0.1-0.3% of carbomer, 0.01-0.1% of acrylates / C10-30 alkyl acrylate cross-linked polymer, 0.1-1% of cetearyl alcohol / cetearyl glucoside, 0.5-1.5% of glyceryl stearate / PEG-100 stearate, 1-2% of polydimethylsiloxane, 1-10% of glycerol, 0.5-2% of polymethyl methacrylate, 0.1-0.5% of polyacrylamide / C13-14 isoparaffin, 0.1-0.5% of parahydroxyacetophenone, 0.1-0.5% of aminomethyl propanol, 0.1-0.3% of phenoxyethanol, 0.1-0.8% of 1,2-hexanediol, and the balance of water.
[0019] Preferably, the EGCG composition comprises 7.1%, carbomer 0.2%, acrylates / C10-30 alkyl acrylate crosspolymer 0.05%, cetearyl alcohol / cetearyl glucoside 0.4%, glyceryl stearate / PEG-100 stearate 1%, polydimethylsiloxane 1.5%, glycerol 5%, polymethyl methacrylate 1%, polyacrylamide / C13-14 isoparaffin / laureth-7 0.22%, parahydroxyacetophenone 0.25%, aminomethyl propanol 0.15%, phenoxyethanol 0.4%, 1,2-hexanediol 0.5%, and the balance water.
[0020] Preferably, the method for preparing the cosmetic comprises the following steps:
[0021] (1) polymethyl methacrylate and glycerol are stirred evenly to obtain material A; p-hydroxyacetophenone and glycerol are heated to 45-55° C. to dissolve to obtain material B; EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate are dispersed evenly to obtain material C;
[0022] (2) stirring and homogenizing water, carbomer, and acrylic acid (esters) / C10-30 alkyl acrylate cross-linked polymer, and then heating to 80-85° C. to obtain material D;
[0023] (3) stirring and homogenizing cetearyl alcohol / cetearyl glucoside, glyceryl stearate / PEG-100 stearate, and polydimethylsiloxane at 80-85° C. to obtain material E;
[0024] (4) adding material A at 80-85° C. and homogenizing, and adding polyacrylamide / C13-14 isoparaffin and homogenizing;
[0025] (5) cooling the mixture to 50-55° C., adding the material B and stirring evenly, and then adding aminomethyl propanol and stirring evenly; cooling the mixture to 40-45° C., adding the material C, phenoxyethanol, and 1,2-hexanediol, stirring evenly, filtering, and discharging the mixture to obtain the cosmetic.
[0026] Preferably, in steps (1)-(5), the stirring rate is each selected from 600-1200 rpm, and the stirring time is each selected from 1-5 min.
[0027] Preferably, in steps (2)-(4), the homogenization rate is each selected from 1500-2500 rpm, and the homogenization time is each selected from 1-5 min.
[0028] Preferably, in step (2), the insulation time is 10-15 minutes.
[0029] Compared with the prior art, the present invention has the following beneficial effects: the EGCG composition of the present invention is stable, fast-acting and mild, and also has significant antioxidant, whitening and anti-aging repair effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is a sample picture after the EGCG composition stability test.
[0031] Figure 2 This is a sample picture after emulsion stability test. DETAILED DESCRIPTION
[0032] In order to better illustrate the purpose, technical scheme and advantages of the present invention, the present invention will be further described below through specific examples. The test methods used in the examples and / or comparative examples are conventional methods unless otherwise specified; the materials, reagents, etc. used can be obtained from commercial channels unless otherwise specified.
[0033] Some of the raw materials used are as follows:
[0034] EGCG was purchased from Guangzhou Xiyuan Biological Co., Ltd.;
[0035] Tricholoma matsutake extract was purchased from Bloomage Biotech Co., Ltd.;
[0036] Yeast fermentation product filtrate was purchased from Bloomage Biotech Co., Ltd.
[0037] Example 1
[0038] This embodiment provides an emulsion, which is composed of the raw material formula in Table 1, and the specific preparation method is as follows:
[0039] (1) polymethyl methacrylate and glycerol are stirred evenly to obtain material A; p-hydroxyacetophenone and glycerol are heated to 50° C. and dissolved until they are completely dissolved into liquid to obtain material B; EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate are dispersed evenly to obtain material C;
[0040] (2) adding water, carbomer, and acrylic acid (esters) / C10-30 alkyl acrylate cross-linked polymer into an emulsifying pot, stirring at a rate of 800 rpm, homogenizing at a rate of 1200 rpm, and then heating to 85° C. and keeping the temperature for 12 min until the mixture is completely dissolved until there is no gel, thereby obtaining material D;
[0041] (3) Cetearyl alcohol / cetearyl glucoside, glyceryl stearate / PEG-100 stearate, and polydimethylsiloxane were added to an oil phase pot, stirred at a rate of 700 rpm, and then heated to 85° C. At this temperature, stirred at a rate of 900 rpm and homogenized at a rate of 2300 rpm for 4 min to obtain material E;
[0042] (4) Pour material D into material E and stir at 800 rpm. Continue to add material A at 85° C. and homogenize at 2300 rpm for 2 min. Add polyacrylamide / C13-14 isoparaffin / laureth-7 and homogenize at 2300 rpm until it is completely emulsified and there is no oil on the surface. Then start cooling.
[0043] (5) Cooling to 50° C., adding material B and stirring evenly at a rate of 1000 rpm, then adding aminomethyl propanol and continuing to stir evenly; cooling again to 40° C., adding material C, phenoxyethanol, and 1,2-hexanediol, continuing to stir evenly, passing the central control, filtering the material (150 mesh filter bag), discharging the material, letting it stand after discharging, inspecting the semi-finished product, and filling and packaging after passing the inspection to obtain an emulsion.
[0044] Table 1
[0045]
[0046]
[0047] Test Example 1: Stability Test
[0048] Test samples: the EGCG composition with antioxidant, whitening and anti-aging effects prepared in Example 4 and the emulsion containing the EGCG composition.
[0049] After all physical and chemical indicators and appearance indicators meet the standards, the samples are divided into five groups for testing:
[0050] (1) Control group, no treatment;
[0051] (2) Normal temperature test group, placed at 25°C for 13 weeks;
[0052] (3) Heat resistance test group, placed at 40℃-48℃ for 13 weeks;
[0053] (4) Cold resistance test group, placed at 5℃-15℃ for 13 weeks;
[0054] (5) Alternating test group: The alternating time was set to be changed every 12 hours, and the temperature was alternately changed between 5℃-15℃ and 48℃, with 7 days as one cycle, for a total of 13 weeks.
[0055] The test samples were observed on the 1st day, 2 months and 3 months after treatment, and the observation items were the appearance, color, fragrance and skin feel of the test samples.
[0056] The stability test time is generally 3 months, and the situation is reviewed every month. If there is a special requirement to extend the time, it will be carried out for 4 or 5 months.) The above experimental plan needs to be compared with the product at room temperature to check the material body and record the test results in the "Formula Stability Test Report". The test results are shown in Table 2, and the stability test chart of the test sample is as follows Figure 1 and 2 shown.
[0057] Table 2
[0058]
[0059]
[0060]
[0061] The results show that the EGCG composition with antioxidant, whitening and anti-aging effects prepared by the present invention and the emulsion containing the EGCG composition can maintain stability for more than three months.
[0062] Test Example 2: Safety Patch Test
[0063] Test sample: the emulsions of Examples 1-11 and Comparative Examples 1-5.
[0064] Subjects: A total of 35 subjects, including 9 males and 26 females, aged 22 to 45 years old, with an average age of 26.1±5.6 years old, met the voluntary inclusion criteria.
[0065] The spot test method is as follows:
[0066] Select qualified patch test equipment and use the closed patch test method to place the patch product containing the test sample (cut into the size of the patch tester, about 50mm 2 ) was placed in a patch tester, and a hypoallergenic tape was applied to the back of the subject. After 24 hours, the test sample was removed, and the skin reaction was observed at 0.5, 24, and 48 hours after removal. A negative control (blank, no treatment) was set up at the same time. The results were recorded according to the skin reaction grading standard of the skin occlusion patch test in Chapter 7 of the "Technical Specifications for Safety of Cosmetics" (2015 edition). The safety patch test results are shown in Table 3.
[0067] Table 3
[0068]
[0069] The results of human skin patch test showed that among 35 subjects, no adverse skin reactions occurred, indicating that the EGCG composition prepared by the present invention is highly safe.
[0070] Test Example 3: Antioxidant Test (DPPH Method)
[0071] Test samples: pretreated emulsions of Examples 1-10 and Comparative Examples 1-5.
[0072] Test principle: Based on the characteristics of DPPH free radical with single electron, strong absorption at 517nm, and purple color of alcohol solution. When there is a free radical scavenger, its absorption gradually disappears due to pairing with its single electron, and its fading degree is quantitatively related to the number of electrons it accepts, so it can be quickly quantitatively analyzed by spectrophotometer. In addition, it should be noted that the sample does not have the effect of antioxidant, and the elimination of free radicals will be inhibited during the test process, resulting in the increase of free radicals in the system, so some data have negative values.
[0073] 1. Reagents and materials:
[0074] (1) Reagents: 0.2 mM DPPH solution (1,1-diphenyl-2-trinitrophenylhydrazine, C 18 H 12N5O6): Weigh 0.007875g DPPH powder and dissolve it in 100mL anhydrous ethanol to prepare 0.2mM DPPH; VC solution (positive control group): Dilute VC with deionized water to 0.001mg / mL, 0.002mg / mL, 0.004mg / mL, 0.006mg / mL, 0.008mg / mL, 0.01mg / mL, 0.02mg / mL and 0.5mg / mL, and place it in a brown bottle for use.
[0075] (2) Instruments and equipment: analytical balance (accurate to 0.001 g), ultrasonic cleaning machine, UV-visible spectrophotometer.
[0076] 2. Test steps:
[0077] Divide into four sample tubes and add samples in sequence according to Table 4.
[0078] Positive control group: set up VC standard control tubes, and add 4.5mL DPPH and 0.5mL VC standard control solution into each tube.
[0079] After mixing the solutions in each tube, react at room temperature in the dark for 30 minutes, adjust the wavelength to zero with distilled water at 517nm, measure the absorbance with a spectrophotometer, and record the data. In data processing, it should be noted that the absolute difference between two independent determination results obtained under repeatability conditions should not exceed 10% of the arithmetic mean.
[0080] The clearance rate (P) was calculated according to formula (1); the test results are shown in Table 5.
[0081]
[0082] In the above formula, T-sample tube absorbance, i.e., the absorbance of the solution after the test sample reacts with DPPH; T0-test sample background absorbance; C-DPPH tube absorbance, i.e., the absorbance of the DPPH solution when no test sample is added; C0-solvent (anhydrous ethanol) background absorbance.
[0083] Table 4
[0084]
[0085]
[0086] Table 5
[0087] Group DPPH removal rate% Example 1 91.88±4.36 Example 2 91.42±2.77 Example 3 94.35±3.74 Example 4 95.79±4.32 Example 5 91.52±0.73 Example 6 92.46±2.48 Example 7 93.12±1.24 Example 8 90.29±4.35 Example 9 90.11±3.68 Example 10 93.46±2.84 Embodiment 11 94.28±1.28 Comparative Example 1 24.45±5.25 Comparative Example 2 53.28±0.64 Comparative Example 3 59.56±4.57 Comparative Example 4 -35.76±3.66 Comparative Example 5 81.92±2.35
[0088] Antioxidant experiments have shown that the EGCG compositions prepared in the embodiments of the present invention have good free radical scavenging and antioxidation effects.
[0089] Test Example 4: Test for inhibition of tyrosinase activity
[0090] Experimental principle: Tyrosinase is the rate-limiting enzyme in the melanin synthesis pathway, and mainly affects the production of melanin by affecting the conversion of tyrosine to DOPA and the oxidation of DOPA to DOPAQUINONE. The principle is that tyrosine or DOPA is converted into DOPAQUINONE under the action of tyrosinase, and the reaction is a color reaction. The inhibition rate of the emulsions of Examples 1-10 and Comparative Examples 1-5 on the activity of tyrosinase is determined by colorimetry.
[0091] 1. Reagents and Materials
[0092] Tyrosinase (25 kU); L-dopa, ≥98%; α-arbutin, ≥99%
[0093] 2. Reagent preparation
[0094] PBS (pH 6.8): Preparation of 0.05 mol / L PBS:
[0095] Solution A: 0.05 mol / L Na2HPO4 solution: weigh 7.099 g of disodium hydrogen phosphate and add distilled water to 1000 mL;
[0096] Solution B: 0.05 mol / L Na2HPO4 solution: weigh 6.803 g potassium dihydrogen phosphate and add distilled water to 1000 mL;
[0097] Mix 50 ml of solution A and 50 ml of solution B.
[0098] Tyrosinase solution: Prepared with pH 6.8 PBS buffer, 100 U / mL, prepared immediately before use;
[0099] DOPA solution: weigh 0.04 g DOPA, dissolve in 40 mL pH 6.8 PBS buffer, and store in dark;
[0100] α-Arbutin: pH 6.8 PBS buffer was diluted sequentially to a 100 μM solution.
[0101] Sample: pretreated mixed solution of the emulsions of Examples 1-10 and Comparative Examples 1-5.
[0102] 3. Determination steps:
[0103] Table 6
[0104]
[0105] The pretreated emulsion mixed solution of Examples 1-10 and Comparative Examples 1-5, 0.05M PBS (pH 6.8), and tyrosinase solution were sequentially added to a test tube; the composition of the reaction solution was shown in Table 6, and it was incubated in a water bath at 37° C. for 10 minutes; 2 mL of DOPA solution was added, and after reacting for 5 minutes, the absorbance was measured at 475 nm;
[0106] Tyrosinase inhibition rate (%) = [1-(ODC-ODD) / (ODA-ODB)] × 100%;
[0107] Absorbance value of ODA-enzyme solution control group;
[0108] The absorbance value of the ODB-enzyme solution was compared with the blank group;
[0109] ODC-absorbance value of sample group;
[0110] OD D -The absorbance value of the blank control of the sample group.
[0111] The absolute difference between two independent measurement results obtained under repeatability conditions shall not exceed 10% of the arithmetic mean.
[0112] The test results are shown in Table 7.
[0113] Table 7
[0114] Group Tyrosinase inhibition rate (%) Example 1 72.58 Example 2 71.41 Example 3 82.36 Example 4 85.44 Example 5 73.27 Example 6 75.32 Example 7 76.45 Example 8 69.32 Example 9 65.48 Example 10 80.32 Embodiment 11 81.76 Comparative Example 1 4.32 Comparative Example 2 60.37 Comparative Example 3 62.48 Comparative Example 4 1.74 Comparative Example 5 64.32
[0115] The results are shown in Table 7. The emulsion containing the EGCG composition significantly inhibits tyrosinase, that is, has a good whitening effect.
[0116] Test Example 5: Elastase Test
[0117] Experimental principle: Collagen forms collagen fibers and reticular fibers, and elastin forms elastic fibers. These three fibers together form the connective tissue of the skin, which makes the skin plump and elastic. Elastase has the ability to decompose collagen, elastin and other proteins. The change in elastin structure is closely related to skin aging. The inhibitory effect of the test sample on the catalysis of elastase and its substrate is detected by an ELISA instrument to determine whether the test sample has the ability to inhibit elastase.
[0118] 1. Reagents and Materials
[0119] Elastase (porcine pancreas, 30 U / mg); N-succinyl-alanine-alanine-alanine-p-nitroaniline, tris(hydroxymethyl)aminomethane, concentrated hydrochloric acid; EGCG (purchased from Guangzhou Xiyuan Biological Co., Ltd.); instruments and equipment: analytical balance (accurate to 0.001g), ultrasonic cleaning machine, pipette, pipette, colorimetric tube, volumetric flask (10mL, 100mL).
[0120] 2. Solution preparation:
[0121] Preparation of 0.2 mol / L Tris-HCl buffer at pH 8.0:
[0122] Solution A: Accurately weigh 4.8456 g of Tris particles, add 100 mL of deionized water, stir and dissolve to obtain a 0.4 mol / L Tris solution;
[0123] Solution B: Take 3.34 mL of concentrated hydrochloric acid and add 96.66 mL of deionized water to dilute to obtain a 0.4 mol / L HCl solution;
[0124] Take 100 ml of solution A and 44.76 ml of solution B, mix them, adjust the pH to 8.0, and add deionized water to make up to 200 ml.
[0125] Elastase solution: Prepare with pH 8.0 Tris-HCL buffer. Take 0.033 g of elastase and add 10 mL of pH 8.0 Tris-HCL buffer to prepare a 100 U / mL elastase solution. Prepare immediately before use.
[0126] Substrate solution: weigh 1.8057 mg of N-succinyl-alanine-alanine-alanine-p-nitroaniline and dissolve it in 10 mL of pH 8.0 Tris-HCl buffer;
[0127] Positive control EGCG group: weigh 0.001 g EGCG powder, dissolve in 1 mL pH 8.0 Tris-HCl buffer to prepare a 1.0 mg / mL solution, and dilute with buffer to 0.5, 0.1, 0.01, 0.005, 0.003, 0.002, 0.001 mg / mL solutions in sequence;
[0128] Sample: pretreated mixed solution of the emulsions of Examples 1-10 and Comparative Examples 1-5.
[0129] 2. Test fluid configuration:
[0130] Table 8
[0131] Composition / (μL) sample Enzyme solution Substrate Buffer blank / 50 100 50 Blank control / 50 / 150 sample 50 50 100 / Sample Control 50 50 / 100
[0132] The enzyme solution, the pretreated emulsion mixture solution of Examples 1-10 and Comparative Examples 1-5 were sequentially placed in a 96-well plate. The composition of the reaction solution was shown in Table 8. The mixture was incubated at room temperature for 60 minutes. The absorbance was detected at 410 nm using an ELISA reader. The data were recorded and saved.
[0133] 3. Elastase inhibition rate (%) calculation formula:
[0134] Elastase inhibition rate (%) = [1-(OD A -OD B ) / (OD C -OD D )]×100;
[0135] OD A -Absorbance value of sample group (containing enzyme and substrate);
[0136] OD B -The absorbance value of the sample control group (containing enzyme but not substrate);
[0137] OD C -The absorbance value of the blank group (containing enzyme, substrate and no sample);
[0138] OD D -The absorbance value of the blank control group (containing enzyme but no substrate or sample).
[0139] The absolute difference between two independent measurement results obtained under repeatability conditions shall not exceed 10% of the arithmetic mean.
[0140] The test results are shown in Table 9:
[0141] Table 9
[0142] Group Elastase inhibition rate (%) Example 1 22.58±0.35 Example 2 20.44±0.67 Example 3 47.67±1.78 Example 4 48.32±2.66 Example 5 26.24±0.92 Example 6 28.32±0.78 Example 7 32.54±1.57 Example 8 19.34±1.48 Example 9 18.47±2.41 Example 10 44.27±0.78 Embodiment 11 46.32±0.64 Comparative Example 1 4.53±2.76 Comparative Example 2 5.44±0.35 Comparative Example 3 6.58±1.72 Comparative Example 4 0.87±2.34 Comparative Example 5 1412±1.58
[0143] The results are shown in Table 9. The emulsion containing the EGCG composition has a significant inhibitory effect on elastase, that is, has a good anti-wrinkle effect.
[0144] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. An EGCG composition, characterized in that The invention comprises the following components in parts by weight: 0.001-0.21 parts of EGCG, 0.4-4.1 parts of Tricholoma matsutake extract and 1-10 parts of yeast fermentation product filtrate.
2. The EGCG composition according to claim 1, wherein The invention comprises the following components in parts by weight: 0.02-0.2 parts of EGCG, 0.5-4 parts of Tricholoma matsutake extract and 1-8 parts of filtrate of yeast fermentation product.
3. The EGCG composition according to claim 1, wherein The mass ratio of EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate is EGCG: Tricholoma matsutake extract: yeast fermentation product filtrate = (0.05-0.2): (0.5-4) (3-6.5).
4. A cosmetic, characterized in that: A composition containing the EGCG according to any one of claims 1 to 3.
5. The cosmetic according to claim 4, characterized in that: In the cosmetic, the mass percentage of the EGCG composition is 1-15%.
6. The cosmetic according to claim 4, characterized in that The types of cosmetics include cleansing, lotion, cream, and mask products.
7. The cosmetic according to claim 4, characterized in that The cosmetics also include at least one of an emollient, a dispersant, a humectant, a preservative, an emulsion stabilizer, a thickener, and a pH adjuster.
8. The cosmetic according to claim 4, characterized in that The cosmetic comprises the following components in percentage by weight: 1-15% of the EGCG composition according to any one of claims 1-3, 0.1-0.3% of carbomer, 0.01-0.1% of acrylates / C10-30 alkyl acrylate cross-linked polymer, 0.1-1% of cetearyl alcohol / cetearyl glucoside, 0.5-1.5% of glyceryl stearate / PEG-100 stearate, 1-2% of polydimethylsiloxane, 1-10% of glycerol, 0.5-2% of polymethyl methacrylate, 0.1-0.5% of polyacrylamide / C13-14 isoparaffin, 0.1-0.5% of p-hydroxyacetophenone, 0.1-0.5% of aminomethyl propanol, 0.1-0.3% of phenoxyethanol, 0.1-0.8% of 1,2-hexanediol, and the balance of water.
9. The cosmetic according to claim 8, characterized in that The cosmetics include the following components in percentage by mass: The EGCG composition of any one of claims 1 to 3 comprises 7.1%, carbomer 0.2%, acrylates / C10-30 alkyl acrylate crosspolymer 0.05%, cetearyl alcohol / cetearyl glucoside 0.4%, glyceryl stearate / PEG-100 stearate 1%, dimethicone 1.5%, glycerin 5%, polymethyl methacrylate 1%, polyacrylamide / C13-14 isoparaffin / laureth-7 0.22%, parahydroxyacetophenone 0.25%, aminomethyl propanol 0.15%, phenoxyethanol 0.4%, 1,2-hexanediol 0.5%, and the balance water.
10. A method for preparing the cosmetic according to claim 8 or 9, characterized in that: The steps include: (1) polymethyl methacrylate and glycerol are stirred evenly to obtain material A; p-hydroxyacetophenone and glycerol are heated to 45-55° C. to dissolve to obtain material B; EGCG, Tricholoma matsutake extract and yeast fermentation product filtrate are dispersed evenly to obtain material C; (2) stirring and homogenizing water, carbomer, and acrylic acid (esters) / C10-30 alkyl acrylate cross-linked polymer, and then heating to 80-85° C. to obtain material D; (3) stirring and homogenizing cetearyl alcohol / cetearyl glucoside, glyceryl stearate / PEG-100 stearate, and polydimethylsiloxane at 80-85° C. to obtain material E; (4) adding material A at 80-85° C. and homogenizing, and adding polyacrylamide / C13-14 isoparaffin and homogenizing; (5) cooling the mixture to 50-55° C., adding the material B and stirring evenly, and then adding aminomethyl propanol and stirring evenly; cooling the mixture to 40-45° C., adding the material C, phenoxyethanol, and 1,2-hexanediol, stirring evenly, filtering, and discharging the mixture to obtain the cosmetic.
Citation Information
Patent Citations
Cosmetic composition containing green tea component
CN103889397A
Cosmetic composition with whitening and skin brightening functions
CN109568203A
Skin composition capable of fading spots and brightening skin and preparation method and application thereof
CN109820739A
Nourishing and repairing lotion and preparation method therefor
CN111434332A
Multi-dimensional anti-wrinkle skin care product system with synergistic effect as well as preparation method and use method of multi-dimensional anti-wrinkle skin care product system
CN118105329A
